{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T04:17:58Z","timestamp":1776399478665,"version":"3.51.2"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["PAK961"],"award-info":[{"award-number":["PAK961"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["PA749\/21-2"],"award-info":[{"award-number":["PA749\/21-2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-52416-0","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T10:55:57Z","timestamp":1726743357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Transvascular transport of nanocarriers for tumor delivery"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7837-7874","authenticated-orcid":false,"given":"Xin","family":"Li","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1425-6093","authenticated-orcid":false,"given":"Yong","family":"Hu","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7114-1095","authenticated-orcid":false,"given":"Xingcai","family":"Zhang","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6785-6645","authenticated-orcid":false,"given":"Xiangyang","family":"Shi","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1672-6650","authenticated-orcid":false,"given":"Wolfgang J.","family":"Parak","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1825-7798","authenticated-orcid":false,"given":"Andrij","family":"Pich","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2024,9,17]]},"reference":[{"key":"52416_CR1","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/d41586-023-03046-x","volume":"622","author":"E Callaway","year":"2023","unstructured":"Callaway, E. & Naddaf, M. Pioneers of mRNA COVID vaccines win medicine Nobel. Nature 622, 228\u2013229 (2023).","journal-title":"Nature"},{"key":"52416_CR2","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nnano.2007.387","volume":"2","author":"D Peer","year":"2007","unstructured":"Peer, D. et al. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751\u2013760 (2007).","journal-title":"Nat. Nanotechnol."},{"key":"52416_CR3","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1021\/acs.chemrev.0c00779","volume":"121","author":"M Izci","year":"2021","unstructured":"Izci, M., Maksoudian, C., Manshian, B. B. & Soenen, S. J. The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors. Chem. Rev. 121, 1746\u20131803 (2021).","journal-title":"Chem. Rev."},{"key":"52416_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nnano.2012.212","volume":"8","author":"A Parodi","year":"2013","unstructured":"Parodi, A. et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nat. Nanotechnol. 8, 61\u201368 (2013).","journal-title":"Nat. Nanotechnol."},{"key":"52416_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06093-5","volume":"9","author":"XD Xue","year":"2018","unstructured":"Xue, X. D. et al. Trojan Horse nanotheranostics with dual transformability and multifunctionality for highly effective cancer treatment. Nat. Commun. 9, 3653 (2018).","journal-title":"Nat. Commun."},{"key":"52416_CR6","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41565-019-0494-y","volume":"14","author":"HL Jang","year":"2019","unstructured":"Jang, H. L. & Sengupta, S. Transcellular transfer of nanomedicine. Nat. Nanotechnol. 14, 731\u2013732 (2019).","journal-title":"Nat. Nanotechnol."},{"key":"52416_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.addr.2019.04.008","volume":"143","author":"ND Donahue","year":"2019","unstructured":"Donahue, N. D., Acar, H. & Wilhelm, S. Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine. Adv. Drug Deliv. Rev. 143, 68\u201396 (2019).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"52416_CR8","doi-asserted-by":"publisher","first-page":"ra15","DOI":"10.1126\/scisignal.aac5820","volume":"9","author":"M Locard-Paulet","year":"2016","unstructured":"Locard-Paulet, M. et al. Phosphoproteomic analysis of interacting tumor and endothelial cells identifies regulatory mechanisms of transendothelial migration. Sci. Signal. 9, ra15 (2016).","journal-title":"Sci. Signal."},{"key":"52416_CR9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/0026-2862(86)90018-X","volume":"31","author":"LE Gerlowski","year":"1986","unstructured":"Gerlowski, L. E. & Jain, R. K. Microvascular permeability of normal and neoplastic tissues. Microvasc. Res. 31, 288\u2013305 (1986).","journal-title":"Microvasc. Res."},{"key":"52416_CR10","first-page":"6387","volume":"46","author":"Y Matsumura","year":"1986","unstructured":"Matsumura, Y. & Maeda, H. A New Concept For Macromolecular Therapeutics In Cancer-Chemotherapy - Mechanism Of Tumoritropic Accumulation Of Proteins And The Antitumor Agent Smancs. Cancer Res. 46, 6387\u20136392 (1986).","journal-title":"Cancer Res."},{"key":"52416_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nrc.2016.108","volume":"17","author":"JJ Shi","year":"2017","unstructured":"Shi, J. J., Kantoff, P. W., Wooster, R. & Farokhzad, O. C. Cancer nanomedicine: progress, challenges and opportunities. Nat. Rev. Cancer 17, 20\u201337 (2017).","journal-title":"Nat. Rev. Cancer"},{"key":"52416_CR12","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1021\/acs.accounts.9b00228","volume":"52","author":"HL He","year":"2019","unstructured":"He, H. L., Liu, L. S., Morin, E. E., Liu, M. & Schwendeman, A. Survey of Clinical Translation of Cancer Nanomedicines-Lessons Learned from Successes and Failures. Acc. Chem. Res. 52, 2445\u20132461 (2019).","journal-title":"Acc. Chem. Res."},{"key":"52416_CR13","doi-asserted-by":"publisher","first-page":"10920","DOI":"10.1021\/acs.chemrev.3c00062","volume":"123","author":"Q Zhou","year":"2023","unstructured":"Zhou, Q. et al. Tumor Abnormality-Oriented Nanomedicine Design. Chem. Rev. 123, 10920\u201310989 (2023).","journal-title":"Chem. Rev."},{"key":"52416_CR14","doi-asserted-by":"publisher","first-page":"16014","DOI":"10.1038\/natrevmats.2016.14","volume":"1","author":"S Wilhelm","year":"2016","unstructured":"Wilhelm, S. et al. Analysis of nanoparticle delivery to tumours. Nat. Rev. Mater. 1, 16014 (2016).","journal-title":"Nat. Rev. Mater."},{"key":"52416_CR15","doi-asserted-by":"publisher","first-page":"9567","DOI":"10.1021\/acsnano.7b07214","volume":"11","author":"A Nel","year":"2017","unstructured":"Nel, A., Ruoslahti, E. & Meng, H. New Insights into \u201cPermeability\u201d as in the Enhanced Permeability and Retention Effect of Cancer Nanotherapeutics. ACS Nano 11, 9567\u20139569 (2017).","journal-title":"ACS Nano"},{"key":"52416_CR16","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1021\/acs.accounts.6b00629","volume":"50","author":"WCW Chan","year":"2017","unstructured":"Chan, W. C. W. Nanomedicine 2.0. Acc. Chem. Res. 50, 627\u2013632 (2017).","journal-title":"Acc. Chem. Res."},{"key":"52416_CR17","doi-asserted-by":"publisher","unstructured":"Wang, Q. et al. Breaking through the basement membrane barrier to improve nanotherapeutic delivery to tumours. Nat. Nanotechnol., https:\/\/doi.org\/10.1038\/s41565-023-01498 (2023).","DOI":"10.1038\/s41565-023-01498"},{"key":"52416_CR18","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41563-019-0566-2","volume":"19","author":"S Sindhwani","year":"2020","unstructured":"Sindhwani, S. et al. The entry of nanoparticles into solid tumours. Nat. Mater. 19, 566\u2013575 (2020).","journal-title":"Nat. Mater."},{"key":"52416_CR19","doi-asserted-by":"publisher","first-page":"1801840","DOI":"10.1002\/adfm.201801840","volume":"28","author":"ZW Zhang","year":"2018","unstructured":"Zhang, Z. W. et al. Rational Design of Nanoparticles with Deep Tumor Penetration for Effective Treatment of Tumor Metastasis. Adv. Funct. Mater. 28, 1801840 (2018).","journal-title":"Adv. Funct. Mater."},{"key":"52416_CR20","doi-asserted-by":"publisher","first-page":"0029","DOI":"10.1038\/s41551-017-0029","volume":"1","author":"W Jiang","year":"2017","unstructured":"Jiang, W. et al. Designing nanomedicine for immuno-oncology. Nat. Biomed. Eng. 1, 0029 (2017).","journal-title":"Nat. Biomed. Eng."},{"key":"52416_CR21","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41563-020-0672-1","volume":"19","author":"S Pandit","year":"2020","unstructured":"Pandit, S., Dutta, D. & Nie, S. M. Active transcytosis and new opportunities for cancer nanomedicine. Nat. Mater. 19, 478\u2013480 (2020).","journal-title":"Nat. Mater."},{"key":"52416_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2015.01.002","volume":"91","author":"H Maeda","year":"2015","unstructured":"Maeda, H. Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity. Adv. Drug Deliv. Rev. 91, 3\u20136 (2015).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"52416_CR23","doi-asserted-by":"publisher","first-page":"7340","DOI":"10.1002\/adma.201601498","volume":"28","author":"S Wang","year":"2016","unstructured":"Wang, S., Huang, P. & Chen, X. Y. Hierarchical Targeting Strategy for Enhanced Tumor Tissue Accumulation\/Retention and Cellular Internalization. Adv. Mater. 28, 7340\u20137364 (2016).","journal-title":"Adv. Mater."},{"key":"52416_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","volume":"20","author":"MJ Mitchell","year":"2021","unstructured":"Mitchell, M. J. et al. Engineering precision nanoparticles for drug delivery. Nat. Rev. Drug Discov. 20, 101\u2013124 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"52416_CR25","doi-asserted-by":"publisher","first-page":"2002589","DOI":"10.1002\/advs.202002589","volume":"8","author":"ZM Li","year":"2021","unstructured":"Li, Z. M. et al. Applications of Surface Modification Technologies in Nanomedicine for Deep Tumor Penetration. Adv. Sci. 8, 2002589 (2021).","journal-title":"Adv. Sci."},{"key":"52416_CR26","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1039\/C9CS00575G","volume":"49","author":"Z Li","year":"2020","unstructured":"Li, Z. et al. Influence of nanomedicine mechanical properties on tumor targeting delivery. Chem. Soc. Rev. 49, 2273\u20132290 (2020).","journal-title":"Chem. Soc. Rev."},{"key":"52416_CR27","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nnano.2012.45","volume":"7","author":"VP Chauhan","year":"2012","unstructured":"Chauhan, V. P. et al. Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner. Nat. Nanotechnol. 7, 383\u2013388 (2012).","journal-title":"Nat. Nanotechnol."},{"key":"52416_CR28","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1111\/j.1349-7006.2009.01323.x","volume":"100","author":"T Seki","year":"2009","unstructured":"Seki, T., Fang, J. & Maeda, H. Enhanced delivery of macromolecular antitumor drugs to tumors by nitroglycerin application. Cancer Sci. 100, 2426\u20132430 (2009).","journal-title":"Cancer Sci."},{"key":"52416_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.matt.2020.04.022","volume":"3","author":"C Feng","year":"2020","unstructured":"Feng, C. et al. Germanene-Based Theranostic Materials for Surgical Adjuvant Treatment: Inhibiting Tumor Recurrence and Wound Infection. Matter 3, 127\u2013144 (2020).","journal-title":"Matter"},{"key":"52416_CR30","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1021\/acsnano.9b05660","volume":"14","author":"JF Liu","year":"2020","unstructured":"Liu, J. F. et al. Use of Oppositely Polarized External Magnets To Improve the Accumulation and Penetration of Magnetic Nanocarriers into Solid Tumors. ACS Nano 14, 142\u2013152 (2020).","journal-title":"ACS Nano"},{"key":"52416_CR31","doi-asserted-by":"publisher","first-page":"eaal0225","DOI":"10.1126\/scitranslmed.aal0225","volume":"9","author":"MA Miller","year":"2017","unstructured":"Miller, M. A. et al. Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts. Sci. Transl. Med. 9, eaal0225 (2017).","journal-title":"Sci. Transl. Med."},{"key":"52416_CR32","doi-asserted-by":"publisher","first-page":"eabf7390","DOI":"10.1126\/sciadv.abf7390","volume":"7","author":"YT Guo","year":"2021","unstructured":"Guo, Y. T. et al. Single-cell analysis reveals effective siRNA delivery in brain tumors with microbubble-enhanced ultrasound and cationic nanoparticles. Sci. Adv. 7, eabf7390 (2021).","journal-title":"Sci. Adv."},{"key":"52416_CR33","doi-asserted-by":"publisher","unstructured":"Gawne, P. J., Ferreira, M., Papaluca, M., Grimm, J. & Decuzzi, P. New opportunities and old challenges in the clinical translation of nanotheranostics. Nat. Rev. Mater. https:\/\/doi.org\/10.1038\/s41578-023-00581-x (2023).","DOI":"10.1038\/s41578-023-00581-x"},{"key":"52416_CR34","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/nbt.3330","volume":"33","author":"E Blanco","year":"2015","unstructured":"Blanco, E., Shen, H. & Ferrari, M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat. Biotechnol. 33, 941\u2013951 (2015).","journal-title":"Nat. Biotechnol."},{"key":"52416_CR35","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nrclinonc.2010.139","volume":"7","author":"RK Jain","year":"2010","unstructured":"Jain, R. K. & Stylianopoulos, T. Delivering nanomedicine to solid tumors. Nat. Rev. Clin. Oncol. 7, 653\u2013664 (2010).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"52416_CR36","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.jconrel.2014.03.057","volume":"190","author":"JW Nichols","year":"2014","unstructured":"Nichols, J. W. & Bae, Y. H. EPR: Evidence and fallacy. J. Controlled Rel. 190, 451\u2013464 (2014).","journal-title":"J. Controlled Rel."},{"key":"52416_CR37","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41565-023-01382-7","volume":"18","author":"L Nuhn","year":"2023","unstructured":"Nuhn, L. Artificial intelligence assists nanoparticles to enter solid tumours. Nat. Nanotechnol. 18, 550\u2013551 (2023).","journal-title":"Nat. Nanotechnol."},{"key":"52416_CR38","doi-asserted-by":"publisher","first-page":"114614","DOI":"10.1016\/j.addr.2022.114614","volume":"191","author":"R Sun","year":"2022","unstructured":"Sun, R. et al. The tumor EPR effect for cancer drug delivery: Current status, limitations, and alternatives. Adv. Drug Deliv. Rev. 191, 114614 (2022).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"52416_CR39","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41565-023-01323-4","volume":"18","author":"M Zhu","year":"2023","unstructured":"Zhu, M. et al. Machine-learning-assisted single-vessel analysis of nanoparticle permeability in tumour vasculatures. Nat. Nanotechnol. 18, 657\u2013666 (2023).","journal-title":"Nat. Nanotechnol."},{"key":"52416_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/entl-2015-0004","volume":"4","author":"B Rothen-Rutishauser","year":"2012","unstructured":"Rothen-Rutishauser, B., Clift, M. J. D., Jud, C., Fink, A. & Wick, P. Human epithelial cells in vitro - Are they an advantageous tool to help understand the nanomeaterial-biological barrier interaction? Eur. Nanotox Lett. 4, 1\u201320 (2012).","journal-title":"Eur. Nanotox Lett."},{"key":"52416_CR41","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","volume":"369","author":"DD Von Hoff","year":"2013","unstructured":"Von Hoff, D. D. et al. Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine. N. Engl. J. Med. 369, 1691\u20131703 (2013).","journal-title":"N. Engl. J. Med."},{"key":"52416_CR42","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.addr.2016.03.008","volume":"110","author":"E Ruoslahti","year":"2017","unstructured":"Ruoslahti, E. Tumor penetrating peptides for improved drug delivery. Adv. Drug Deliv. Rev. 110, 3\u201312 (2017).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"52416_CR43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jconrel.2015.01.011","volume":"201","author":"T Kadonosono","year":"2015","unstructured":"Kadonosono, T. et al. Cell penetrating peptides improve tumor delivery of cargos through neuropilin-1-dependent extravasation. J. Controlled Rel. 201, 14\u201321 (2015).","journal-title":"J. Controlled Rel."},{"key":"52416_CR44","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1126\/science.1183057","volume":"328","author":"KN Sugahara","year":"2010","unstructured":"Sugahara, K. N. et al. Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs. Science 328, 1031\u20131035 (2010).","journal-title":"Science"},{"key":"52416_CR45","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41573-021-00139-y","volume":"20","author":"GC Terstappen","year":"2021","unstructured":"Terstappen, G. C., Meyer, A. H., Bell, R. D. & Zhang, W. Strategies for delivering therapeutics across the blood-brain barrier. Nat. Rev. Drug Discov. 20, 362\u2013383 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"52416_CR46","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41563-023-01481-9","volume":"22","author":"DE Tylawsky","year":"2023","unstructured":"Tylawsky, D. E. et al. P-selectin-targeted nanocarriers induce active crossing of the blood-brain barrier via caveolin-1-dependent transcytosis. Nat. Mater. 22, 391\u2013399 (2023).","journal-title":"Nat. Mater."},{"key":"52416_CR47","first-page":"345ra387","volume":"10","author":"Y Shamay","year":"2018","unstructured":"Shamay, Y. et al. P-selectin is a nanotherapeutic delivery target in the tumor microenvironment. Sci. Transl. Med. 10, 345ra387 (2018).","journal-title":"Sci. Transl. Med."},{"key":"52416_CR48","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41565-019-0485-z","volume":"14","author":"Q Zhou","year":"2019","unstructured":"Zhou, Q. et al. Enzyme-activatable polymer-drug conjugate augments tumour penetration and treatment efficacy. Nat. Nanotechnol. 14, 799\u2013809 (2019).","journal-title":"Nat. Nanotechnol."},{"key":"52416_CR49","doi-asserted-by":"publisher","first-page":"4890","DOI":"10.1021\/acsnano.0c00974","volume":"14","author":"GW Wang","year":"2020","unstructured":"Wang, G. W. et al. Enzyme-Triggered Transcytosis of Dendrimer-Drug Conjugate for Deep Penetration into Pancreatic Tumors. ACS Nano 14, 4890\u20134904 (2020).","journal-title":"ACS Nano"},{"key":"52416_CR50","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/s41551-021-00701-4","volume":"5","author":"SQ Chen","year":"2021","unstructured":"Chen, S. Q. et al. Enhanced tumour penetration and prolonged circulation in blood of polyzwitterion-drug conjugates with cell-membrane affinity. Nat. Biomed. Eng. 5, 1019 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"52416_CR51","doi-asserted-by":"publisher","first-page":"101022","DOI":"10.1016\/j.nantod.2020.101022","volume":"36","author":"L Jia","year":"2021","unstructured":"Jia, L. et al. Ultrasound-enhanced precision tumor theranostics using cell membrane-coated and pH-responsive nanoclusters assembled from ultrasmall iron oxide nanoparticles. Nano Today 36, 101022 (2021).","journal-title":"Nano Today"},{"key":"52416_CR52","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.ultrasmedbio.2015.03.010","volume":"41","author":"A Delalande","year":"2015","unstructured":"Delalande, A., Leduc, C., Midoux, P., Postema, M. & Pichon, C. Efficient Gene Delivery By Sonoporation Is Associated With Microbubble Entry Into Cells And The Clathrin-Dependent Endocytosis Pathway. Ultrasound Med. Biol. 41, 1913\u20131926 (2015).","journal-title":"Ultrasound Med. Biol."},{"key":"52416_CR53","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/nnano.2015.342","volume":"11","author":"Y Matsumoto","year":"2016","unstructured":"Matsumoto, Y. et al. Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery. Nat. Nanotechnol. 11, 533\u2013538 (2016).","journal-title":"Nat. Nanotechnol."},{"key":"52416_CR54","doi-asserted-by":"publisher","first-page":"14080","DOI":"10.1021\/acsnano.1c04510","volume":"15","author":"BR Kingston","year":"2021","unstructured":"Kingston, B. R. et al. Specific Endothelial Cells Govern Nanoparticle Entry into Solid Tumors. ACS Nano 15, 14080\u201314094 (2021).","journal-title":"ACS Nano"},{"key":"52416_CR55","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.addr.2014.12.003","volume":"91","author":"Q Wang","year":"2015","unstructured":"Wang, Q. et al. Non-genetic engineering of cells for drug delivery and cell-based therapy. Adv. Drug Deliv. Rev. 91, 125\u2013140 (2015).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"52416_CR56","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jconrel.2014.03.050","volume":"190","author":"AC Anselmo","year":"2014","unstructured":"Anselmo, A. C. & Mitragotri, S. Cell-mediated delivery of nanoparticles: Taking advantage of circulatory cells to target nanoparticles. J. Controlled Rel. 190, 531\u2013541 (2014).","journal-title":"J. Controlled Rel."},{"key":"52416_CR57","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1517\/17425247.2011.559457","volume":"8","author":"EV Batrakova","year":"2011","unstructured":"Batrakova, E. V., Gendelman, H. E. & Kabanov, A. V. Cell-mediated drug delivery. Expert Opin. Drug Deliv. 8, 415\u2013433 (2011).","journal-title":"Expert Opin. Drug Deliv."},{"key":"52416_CR58","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nri3399","volume":"13","author":"E Kolaczkowska","year":"2013","unstructured":"Kolaczkowska, E. & Kubes, P. Neutrophil recruitment and function in health and inflammation. Nat. Rev. Immunol. 13, 159\u2013175 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"52416_CR59","doi-asserted-by":"publisher","first-page":"1805557","DOI":"10.1002\/adma.201805557","volume":"30","author":"WZ Zhang","year":"2018","unstructured":"Zhang, W. Z. et al. Nanoparticle-Laden Macrophages for Tumor-Tropic Drug Delivery. Adv. Mater. 30, 1805557 (2018).","journal-title":"Adv. Mater."},{"key":"52416_CR60","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1038\/nm.2198","volume":"16","author":"MT Stephan","year":"2010","unstructured":"Stephan, M. T., Moon, J. J., Um, S. H., Bershteyn, A. & Irvine, D. J. Therapeutic cell engineering with surface-conjugated synthetic nanoparticles. Nat. Med. 16, 1035\u20131041 (2010).","journal-title":"Nat. Med."},{"key":"52416_CR61","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrc1782","volume":"6","author":"KE de Visser","year":"2006","unstructured":"de Visser, K. E., Eichten, A. & Coussens, L. M. Paradoxical roles of the immune system during cancer development. Nat. Rev. Cancer 6, 24\u201337 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"52416_CR62","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nri3789","volume":"15","author":"T Kitamura","year":"2015","unstructured":"Kitamura, T., Qian, B. Z. & Pollard, J. W. Immune cell promotion of metastasis. Nat. Rev. Immunol. 15, 73\u201386 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"52416_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-017-0258-5","volume":"15","author":"P Nold","year":"2017","unstructured":"Nold, P. et al. Optimizing conditions for labeling of mesenchymal stromal cells (MSCs) with gold nanoparticles: a prerequisite for in vivo tracking of MSCs. J. Nanobiotechnol. 15, 24 (2017).","journal-title":"J. Nanobiotechnol."},{"key":"52416_CR64","doi-asserted-by":"publisher","DOI":"10.1007\/s40828-021-00159-6","volume":"8","author":"YA Kang","year":"2022","unstructured":"Kang, Y. A. et al. Quantitative considerations about the size dependence of cellular entry and excretion of colloidal nanoparticles for different cell types. Chemtexts 8, 9 (2022).","journal-title":"Chemtexts"},{"key":"52416_CR65","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/nnano.2015.111","volume":"10","author":"WG Kreyling","year":"2015","unstructured":"Kreyling, W. G. et al. In vivo integrity of polymer-coated gold nanoparticles. Nat. Nanotechnol. 10, 619\u2013623 (2015).","journal-title":"Nat. Nanotechnol."},{"key":"52416_CR66","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/s41551-021-00815-9","volume":"6","author":"H Wang","year":"2022","unstructured":"Wang, H. et al. Genetically engineered and enucleated human mesenchymal stromal cells for the targeted delivery of therapeutics to diseased tissue. Nat. Biomed. Eng. 6, 882\u2013897 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"52416_CR67","doi-asserted-by":"publisher","first-page":"184ra159","DOI":"10.1126\/scitranslmed.3005365","volume":"5","author":"KS Aboody","year":"2013","unstructured":"Aboody, K. S. et al. Neural Stem Cell-Mediated Enzyme\/Prodrug Therapy for Glioma: Preclinical Studies. Sci. Transl. Med. 5, 184ra159 (2013).","journal-title":"Sci. Transl. Med."},{"key":"52416_CR68","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","volume":"21","author":"D Hanahan","year":"2012","unstructured":"Hanahan, D. & Coussens, L. M. Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment. Cancer Cell 21, 309\u2013322 (2012).","journal-title":"Cancer Cell"},{"key":"52416_CR69","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nnano.2017.54","volume":"12","author":"JW Xue","year":"2017","unstructured":"Xue, J. W. et al. Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence. Nat. Nanotechnol. 12, 692\u2013700 (2017).","journal-title":"Nat. Nanotechnol."},{"key":"52416_CR70","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1126\/science.aad9464","volume":"350","author":"J Di Domizio","year":"2015","unstructured":"Di Domizio, J. & Gilliet, M. Designer cells finely tuned for therapy. Science 350, 1478\u20131479 (2015).","journal-title":"Science"},{"key":"52416_CR71","doi-asserted-by":"publisher","first-page":"11800","DOI":"10.1021\/acsnano.5b05583","volume":"9","author":"DF Chu","year":"2015","unstructured":"Chu, D. F., Gao, J. & Wang, Z. J. Neutrophil-Mediated Delivery of Therapeutic Nanoparticles across Blood Vessel Barrier for Treatment of Inflammation and Infection. ACS Nano 9, 11800\u201311811 (2015).","journal-title":"ACS Nano"},{"key":"52416_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14963-0","volume":"11","author":"M Li","year":"2020","unstructured":"Li, M. et al. Chemotaxis-driven delivery of nano-pathogenoids for complete eradication of tumors post-phototherapy. Nat. Commun. 11, 1126 (2020).","journal-title":"Nat. Commun."},{"key":"52416_CR73","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1021\/jacs.9b11046","volume":"142","author":"LY Zheng","year":"2020","unstructured":"Zheng, L. Y. et al. In Vivo Monocyte\/Macrophage-Hitchhiked Intratumoral Accumulation of Nanomedicines for Enhanced Tumor Therapy. J. Am. Chem. Soc. 142, 382\u2013391 (2020).","journal-title":"J. Am. Chem. Soc."},{"key":"52416_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-013-1084-8","volume":"113","author":"JC Akers","year":"2013","unstructured":"Akers, J. C., Gonda, D., Kim, R., Carter, B. S. & Chen, C. C. Biogenesis of extracellular vesicles (EV): exosomes, microvesicles, retrovirus-like vesicles, and apoptotic bodies. J. Neuro Oncol. 113, 1\u201311 (2013).","journal-title":"J. Neuro Oncol."},{"key":"52416_CR75","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s00262-011-1149-5","volume":"61","author":"M Palma","year":"2012","unstructured":"Palma, M. et al. Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria. Cancer Immunol. Immunother. 61, 865\u2013879 (2012).","journal-title":"Cancer Immunol. Immunother."},{"key":"52416_CR76","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41565-021-00997-y","volume":"17","author":"JW Myerson","year":"2022","unstructured":"Myerson, J. W. et al. Supramolecular arrangement of protein in nanoparticle structures predicts nanoparticle tropism for neutrophils in acute lung inflammation. Nat. Nanotechnol. 17, 86\u201397 (2022).","journal-title":"Nat. Nanotechnol."},{"key":"52416_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41565-021-00981-6","volume":"17","author":"J Kim","year":"2022","unstructured":"Kim, J. & Sahay, G. Nanomedicine hitchhikes on neutrophils to the inflamed lung. Nat. Nanotechnol. 17, 1\u20132 (2022).","journal-title":"Nat. Nanotechnol."},{"key":"52416_CR78","doi-asserted-by":"publisher","first-page":"2003598","DOI":"10.1002\/adma.202003598","volume":"32","author":"JY Che","year":"2020","unstructured":"Che, J. Y. et al. Neutrophils Enable Local and Non-Invasive Liposome Delivery to Inflamed Skeletal Muscle and Ischemic Heart. Adv. Mater. 32, 2003598 (2020).","journal-title":"Adv. Mater."},{"key":"52416_CR79","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.1021\/acsnano.5b07817","volume":"10","author":"A Anbrosone","year":"2016","unstructured":"Anbrosone, A. et al. Control of Wnt\/beta-Catenin Signaling Pathway in Vivo via Light Responsive Capsules. ACS Nano 10, 4828\u20134834 (2016).","journal-title":"ACS Nano"},{"key":"52416_CR80","doi-asserted-by":"publisher","first-page":"100034","DOI":"10.1016\/j.engmic.2022.100034","volume":"2","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y. & Han, Y. Engineered bacteria as drug delivery vehicles: Principles and prospects. Eng. Microbiol. 2, 100034 (2022).","journal-title":"Eng. Microbiol."},{"key":"52416_CR81","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/nrmicro.2016.178","volume":"15","author":"M Coureuil","year":"2017","unstructured":"Coureuil, M., Lecuyer, H., Bourdoulous, S. & Nassif, X. A journey into the brain: insight into how bacterial pathogens cross blood-brain barriers. Nat. Rev. Microbiol. 15, 149\u2013159 (2017).","journal-title":"Nat. Rev. Microbiol."},{"key":"52416_CR82","doi-asserted-by":"publisher","first-page":"e13132","DOI":"10.1111\/cmi.13132","volume":"22","author":"L Le Guennec","year":"2020","unstructured":"Le Guennec, L., Coureuil, M., Nassif, X. & Bourdoulous, S. Strategies used by bacterial pathogens to cross the blood-brain barrier. Cell. Microbiol. 22, e13132 (2020).","journal-title":"Cell. Microbiol."},{"key":"52416_CR83","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.nbd.2005.09.007","volume":"21","author":"J Sellner","year":"2006","unstructured":"Sellner, J. & Leib, S. L. In bacterial meningitis cortical brain damage is associated with changes in parenchymal MMP-9\/TIMP-1 ratio and increased collagen type IV degradation. Neurobiol. Dis. 21, 647\u2013656 (2006).","journal-title":"Neurobiol. Dis."},{"key":"52416_CR84","doi-asserted-by":"publisher","first-page":"119226","DOI":"10.1016\/j.biomaterials.2019.119226","volume":"214","author":"F Chen","year":"2019","unstructured":"Chen, F. et al. Nanophotosensitizer-engineered Salmonella bacteria with hypoxia targeting and photothermal-assisted mutual bioaccumulation for solid tumor therapy. Biomaterials 214, 119226 (2019).","journal-title":"Biomaterials"},{"key":"52416_CR85","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/nrc2934","volume":"10","author":"NS Forbes","year":"2010","unstructured":"Forbes, N. S. Engineering the perfect (bacterial) cancer therapy. Nat. Rev. Cancer 10, 784\u2013793 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"52416_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32837-5","volume":"13","author":"R Sun","year":"2022","unstructured":"Sun, R. et al. Bacteria loaded with glucose polymer and photosensitive ICG silicon-nanoparticles for glioblastoma photothermal immunotherapy. Nat. Commun. 13, 5127 (2022).","journal-title":"Nat. Commun."},{"key":"52416_CR87","doi-asserted-by":"publisher","unstructured":"Wang, C. et al. Oncolytic mineralized bacteria as potent locally administered immunotherapeutics. Nat. Biomed. Eng. https:\/\/doi.org\/10.1038\/s41551-024-01191-w (2024).","DOI":"10.1038\/s41551-024-01191-w"},{"key":"52416_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12088-7","volume":"10","author":"J Tang","year":"2019","unstructured":"Tang, J. et al. Multifunctional nanoagents for ultrasensitive imaging and photoactive killing of Gram-negative and Gram-positive bacteria. Nat. Commun. 10, 4057 (2019).","journal-title":"Nat. Commun."},{"key":"52416_CR89","doi-asserted-by":"publisher","first-page":"5995","DOI":"10.1021\/acsnano.8b02235","volume":"12","author":"W Chen","year":"2018","unstructured":"Chen, W. et al. Bacteria-Driven Hypoxia Targeting for Combined Biotherapy and Photothermal Therapy. ACS Nano 12, 5995\u20136005 (2018).","journal-title":"ACS Nano"},{"key":"52416_CR90","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41568-018-0070-z","volume":"18","author":"S Zhou","year":"2018","unstructured":"Zhou, S., Gravekamp, C., Bermudes, D. & Liu, K. Tumour-targeting bacteria engineered to fight cancer. Nat. Rev. Cancer 18, 727\u2013743 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"52416_CR91","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1021\/acs.nanolett.3c00563","volume":"23","author":"J Lu","year":"2023","unstructured":"Lu, J. et al. Inactive Trojan Bacteria as Safe Drug Delivery Vehicles Crossing the Blood-Brain Barrier. Nano Lett. 23, 4326\u20134333 (2023).","journal-title":"Nano Lett."},{"key":"52416_CR92","doi-asserted-by":"publisher","first-page":"2106669","DOI":"10.1002\/adma.202106669","volume":"34","author":"L Wang","year":"2022","unstructured":"Wang, L., Cao, Z., Zhang, M., Lin, S. & Liu, J. Spatiotemporally Controllable Distribution of Combination Therapeutics in Solid Tumors by Dually Modified Bacteria. Adv. Mater. 34, 2106669 (2022).","journal-title":"Adv. Mater."},{"key":"52416_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26367-9","volume":"12","author":"V Raman","year":"2021","unstructured":"Raman, V. et al. Intracellular delivery of protein drugs with an autonomously lysing bacterial system reduces tumor growth and metastases. Nat. Commun. 12, 6116 (2021).","journal-title":"Nat. Commun."},{"key":"52416_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17425247.2017.1262346","volume":"14","author":"R van der Meel","year":"2017","unstructured":"van der Meel, R., Lammers, T. & Hennink, W. E. Cancer nanomedicines: oversold or underappreciated? Expert Opin. Drug Deliv. 14, 1\u20135 (2017).","journal-title":"Expert Opin. Drug Deliv."},{"key":"52416_CR95","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/s41565-020-0759-5","volume":"15","author":"W Poon","year":"2020","unstructured":"Poon, W., Kingston, B. R., Ouyang, B., Ngo, W. & Chan, W. C. W. A framework for designing delivery systems. Nat. Nanotechnol. 15, 819\u2013829 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"52416_CR96","doi-asserted-by":"publisher","first-page":"128ra139","DOI":"10.1126\/scitranslmed.3003651","volume":"4","author":"J Hrkach","year":"2012","unstructured":"Hrkach, J. et al. Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile. Sci. Transl. Med. 4, 128ra139 (2012).","journal-title":"Sci. Transl. Med."},{"key":"52416_CR97","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/nrd2110","volume":"5","author":"NE Sharpless","year":"2006","unstructured":"Sharpless, N. E. & DePinho, R. A. Model organisms - The mighty mouse: genetically engineered mouse models in cancer drug development. Nat. Rev. Drug Discov. 5, 741\u2013754 (2006).","journal-title":"Nat. Rev. Drug Discov."},{"key":"52416_CR98","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.tibtech.2017.12.001","volume":"36","author":"M Landgraf","year":"2018","unstructured":"Landgraf, M., McGovern, J. A., Friedl, P. & Hutmacher, D. W. Rational Design of Mouse Models for Cancer Research. Trends Biotechnol. 36, 242\u2013251 (2018).","journal-title":"Trends Biotechnol."},{"key":"52416_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3718","volume":"4","author":"A Albanese","year":"2013","unstructured":"Albanese, A., Lam, A. K., Sykes, E. A., Rocheleau, J. V. & Chan, W. C. W. Tumour-on-a-chip provides an optical window into nanoparticle tissue transport. Nat. Commun. 4, 2718 (2013).","journal-title":"Nat. Commun."},{"key":"52416_CR100","doi-asserted-by":"publisher","first-page":"11600","DOI":"10.1021\/acsnano.8b06846","volume":"12","author":"HF Wang","year":"2018","unstructured":"Wang, H. F. et al. Tumor-Vasculature-on-a-Chip for Investigating Nanoparticle Extravasation and Tumor Accumulation. ACS Nano 12, 11600\u201311609 (2018).","journal-title":"ACS Nano"},{"key":"52416_CR101","doi-asserted-by":"publisher","first-page":"e1906274","DOI":"10.1002\/adma.201906274","volume":"32","author":"YY Chen","year":"2020","unstructured":"Chen, Y. Y., Syed, A. M., MacMillan, P., Rocheleau, J. V. & Chan, W. C. W. Flow Rate Affects Nanoparticle Uptake into Endothelial Cells. Adv. Mater. 32, e1906274 (2020).","journal-title":"Adv. Mater."},{"key":"52416_CR102","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1126\/science.1226338","volume":"338","author":"ZL Cheng","year":"2012","unstructured":"Cheng, Z. L., Al Zaki, A., Hui, J. Z., Muzykantov, V. R. & Tsourkas, A. Multifunctional Nanoparticles: Cost Versus Benefit of Adding Targeting and Imaging Capabilities. Science 338, 903\u2013910 (2012).","journal-title":"Science"},{"key":"52416_CR103","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/nnano.2011.166","volume":"6","author":"H Cabral","year":"2011","unstructured":"Cabral, H. et al. Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat. Nanotechnol. 6, 815\u2013823 (2011).","journal-title":"Nat. Nanotechnol."},{"key":"52416_CR104","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1038\/s41565-019-0567-y","volume":"14","author":"R van der Meel","year":"2019","unstructured":"van der Meel, R. et al. Smart cancer nanomedicine. Nat. Nanotechnol. 14, 1007\u20131017 (2019).","journal-title":"Nat. Nanotechnol."},{"key":"52416_CR105","doi-asserted-by":"publisher","unstructured":"May, J.-N. et al. Histopathological biomarkers for predicting the tumour accumulation of nanomedicines. Nat. Biomed. Eng. https:\/\/doi.org\/10.1038\/s41551-024-01197-4 (2024).","DOI":"10.1038\/s41551-024-01197-4"},{"key":"52416_CR106","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/s41565-019-0497-8","volume":"14","author":"T Lammers","year":"2019","unstructured":"Lammers, T. & Storm, G. Setting standards to promote progress in bio-nano science. Nat. Nanotechnol. 14, 626\u2013626 (2019).","journal-title":"Nat. Nanotechnol."},{"key":"52416_CR107","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41565-018-0246-4","volume":"13","author":"M Faria","year":"2018","unstructured":"Faria, M. et al. Minimum information reporting in bio-nano experimental literature. Nat. Nanotechnol. 13, 777\u2013785 (2018).","journal-title":"Nat. Nanotechnol."},{"key":"52416_CR108","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41565-019-0496-9","volume":"14","author":"HS Leong","year":"2019","unstructured":"Leong, H. S. et al. On the issue of transparency and reproducibility in nanomedicine. Nat. Nanotechnol. 14, 629\u2013635 (2019).","journal-title":"Nat. Nanotechnol."},{"key":"52416_CR109","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1038\/s41563-021-01047-7","volume":"20","author":"I de Lazaro","year":"2021","unstructured":"de Lazaro, I. & Mooney, D. J. Obstacles and opportunities in a forward vision for cancer nanomedicine. Nat. Mater. 20, 1469\u20131479 (2021).","journal-title":"Nat. Mater."},{"key":"52416_CR110","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.taap.2017.03.011","volume":"323","author":"X Bai","year":"2017","unstructured":"Bai, X. et al. Toward a systematic exploration of nano-bio interactions. Toxicol. Appl. Pharmacol. 323, 66\u201373 (2017).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"52416_CR111","doi-asserted-by":"publisher","first-page":"119902","DOI":"10.1016\/j.biomaterials.2020.119902","volume":"240","author":"Q Zhou","year":"2020","unstructured":"Zhou, Q. et al. Tumor extravasation and infiltration as barriers of nanomedicine for high efficacy: The current status and transcytosis strategy. Biomaterials 240, 119902 (2020).","journal-title":"Biomaterials"},{"key":"52416_CR112","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/s41563-020-0755-z","volume":"19","author":"B Ouyang","year":"2020","unstructured":"Ouyang, B. et al. The dose threshold for nanoparticle tumour delivery. Nat. Mater. 19, 1362 (2020).","journal-title":"Nat. Mater."},{"key":"52416_CR113","doi-asserted-by":"publisher","first-page":"E1142","DOI":"10.1073\/pnas.1521265113","volume":"113","author":"EA Sykes","year":"2016","unstructured":"Sykes, E. A. et al. Tailoring nanoparticle designs to target cancer based on tumor pathophysiology. Proc. Natl Acad. Sci. USA 113, E1142\u2013E1151 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"52416_CR114","doi-asserted-by":"publisher","unstructured":"Thurber, G. M. & Weissleder, R. A Systems Approach for Tumor Pharmacokinetics. Plos One 6, https:\/\/doi.org\/10.1371\/journal.pone.0024696 (2011).","DOI":"10.1371\/journal.pone.0024696"},{"key":"52416_CR115","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jconrel.2015.04.006","volume":"207","author":"SN Ekdawi","year":"2015","unstructured":"Ekdawi, S. N. et al. Spatial and temporal mapping of heterogeneity in liposome uptake and microvascular distribution in an orthotopic tumor xenograft model. J. Controlled Rel. 207, 101\u2013111 (2015).","journal-title":"J. Controlled Rel."},{"key":"52416_CR116","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jconrel.2016.02.016","volume":"227","author":"DL Stirland","year":"2016","unstructured":"Stirland, D. L., Matsumoto, Y., Toh, K., Kataoka, K. & Bae, Y. H. Analyzing spatiotemporal distribution of uniquely fluorescent nanoparticles in xenograft tumors. J. Controlled Rel. 227, 38\u201344 (2016).","journal-title":"J. Controlled Rel."},{"key":"52416_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14293","volume":"8","author":"MF Cuccarese","year":"2017","unstructured":"Cuccarese, M. F. et al. Heterogeneity of macrophage infiltration and therapeutic response in lung carcinoma revealed by 3D organ imaging. Nat. Commun. 8, 14293 (2017).","journal-title":"Nat. Commun."},{"key":"52416_CR118","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","volume":"25","author":"EJ Topol","year":"2019","unstructured":"Topol, E. J. High-performance medicine: the convergence of human and artificial intelligence. Nat. Med. 25, 44\u201356 (2019).","journal-title":"Nat. Med."},{"key":"52416_CR119","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/s41551-019-0351-1","volume":"3","author":"G Yamankurt","year":"2019","unstructured":"Yamankurt, G. et al. Exploration of the nanomedicine-design space with high-throughput screening and machine learning. Nat. Biomed. Eng. 3, 318\u2013327 (2019).","journal-title":"Nat. Biomed. Eng."},{"key":"52416_CR120","doi-asserted-by":"publisher","unstructured":"Yaari, Z. et al. Theranostic barcoded nanoparticles for personalized cancer medicine. Nat. Commun. 7, https:\/\/doi.org\/10.1038\/ncomms13325 (2016).","DOI":"10.1038\/ncomms13325"},{"key":"52416_CR121","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1021\/acs.nanolett.8b00432","volume":"18","author":"K Paunovska","year":"2018","unstructured":"Paunovska, K. et al. A Direct Comparison of in Vitro and in Vivo Nucleic Acid Delivery Mediated by Hundreds of Nanoparticles Reveals a Weak Correlation. Nano Lett. 18, 2148\u20132157 (2018).","journal-title":"Nano Lett."},{"key":"52416_CR122","doi-asserted-by":"publisher","first-page":"eabm5551","DOI":"10.1126\/science.abm5551","volume":"377","author":"N Boehnke","year":"2022","unstructured":"Boehnke, N. et al. Massively parallel pooled screening reveals genomic determinants of nanoparticle delivery. Science 377, eabm5551 (2022).","journal-title":"Science"},{"key":"52416_CR123","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jmir.2020.01.008","volume":"51","author":"C Chamunyonga","year":"2020","unstructured":"Chamunyonga, C., Edwards, C., Caldwell, P. & Rutledge, P. The Impact of Artificial Intelligence and Machine Learning in Radiation Therapy: Considerations for Future Curriculum Enhancement. J. Med. Imaging Radiat. Sci. 51, 214\u2013220 (2020).","journal-title":"J. Med. Imaging Radiat. Sci."},{"key":"52416_CR124","doi-asserted-by":"publisher","first-page":"e1902798","DOI":"10.1002\/adma.201902798","volume":"31","author":"K Paunovska","year":"2019","unstructured":"Paunovska, K., Loughrey, D., Sago, C. D., Langer, R. & Dahlman, J. E. Using Large Datasets to Understand Nanotechnology. Adv. Mater. 31, e1902798 (2019).","journal-title":"Adv. Mater."},{"key":"52416_CR125","doi-asserted-by":"publisher","first-page":"8023","DOI":"10.1021\/acsnano.9b02774","volume":"13","author":"J Lazarovits","year":"2019","unstructured":"Lazarovits, J. et al. Supervised Learning and Mass Spectrometry Predicts the in Vivo Fate of Nanomaterials. ACS Nano 13, 8023\u20138034 (2019).","journal-title":"ACS Nano"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52416-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52416-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52416-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T22:01:40Z","timestamp":1726869700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-52416-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":125,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["52416"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-52416-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,17]]},"assertion":[{"value":"5 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8172"}}